Wearable Injectors Market by Type of Device (Patch Pump / On Body Injectors and Wearable Infusion Pump), Usability (Disposable and Reusable), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, On

Wearable Injectors Market by Type of Device (Patch Pump / On Body Injectors and Wearable Infusion Pump), Usability (Disposable and Reusable), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncological Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, Till 2035

Wearable Injectors Market: Overview

As per Roots Analysis, the global wearable injectors market is estimated to grow from USD 4.3 billion in the current year to USD 12.10 billion by 2035, at a CAGR of 9% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Device

• Patch Pump / Injectors
• Infusion Pump / Injectors

Usability

• Disposable
• Reusable

Therapeutic Area

• Autoimmune Disorders
• Cardiovascular Disorders
• Metabolic Disorders
• Neurological Disorders
• Oncological Disorders
• Other Disorders

Key Geographical Regions

• North America
• Europe
• Asia
• Latin America
• Middle East and North Africa

WEARABLE INJECTORS MARKET: GROWTH AND TRENDS

The last few years have witnessed a rising incidence of chronic illnesses across the globe. Long term clinical conditions, such as neurological disorders, cardiovascular disorders, chronic pain and oncological disorders, have been shown to impose a significant burden on the modern healthcare system and those who suffer from such diseases. The current treatment options include administration of prescribed medications through oral and parenteral routes. Of these options, parenteral administration of drugs is the most prevalent method. However, parenteral administration poses several challenges for patient convenience, such as frequent dosing, dosing errors, occurrence of needlestick injuries and risk of microbial contamination.

In recent years, the pharmaceutical industry has witnessed many technological advancements with the emergence of novel drug delivery devices, such as autoinjectors, wearable injectors and pen injectors. It is worth highlighting that large volume wearable injectors have proven to improve medication adherence by simplifying the administration process. In addition, advanced wearable injection devices offer several advantages, such as wide range of dosing options and in-built safety mechanisms. As a result, wearable injectors have become the preferred choice for subcutaneous administration of drugs in home-care settings. The large volume wearable injectors market is likely to witness a substantial growth in the future as more patients shift from conventional to user-friendly drug delivery alternatives.

WEARABLE INJECTORS MARKET: KEY INSIGHTS

The report delves into the current state of the global wearable injectors market and identifies potential growth opportunities within the industry. Some key findings from the report include:

1. Presently, over 40 wearable injectors and drug device combinations are available or being developed by close to 25 manufacturers; a relatively larger proportion of these players were established before 2000.

2. Nearly 90% of the large volume wearable injectors that can deliver non-insulin drugs targeting multiple disease indications have been commercialized.

3. 45 large volume wearable injectors are being manufactured for insulin delivery by players across the globe; ~60% of these injectors are patch pumps / injectors having the capability to deliver both basal and bolus doses.

4. The market landscape is highly fragmented, featuring the presence of both new entrants and established players based across different geographical regions; close to 45% of such players are mid-sized companies.

5. In pursuit of gaining a competitive edge, companies engaged in the manufacturing of large volume wearable injectors are presently focusing on the integration of advanced features into their respective product offerings.

6. The rising interest in this domain is also reflected by the number of partnerships that have been inked in the recent past, involving both international and local stakeholders.

7. Close to 300 patents have been filed / granted for large volume wearable injectors by industry and non-industry players to protect the intellectual property generated within this field.

8. An evaluation of both marketed / pipeline products reveals that there are a variety of drugs / product candidates that are likely to be considered for administration via large volume wearable injectors.

9. Nearly 160 clinical trials have been registered to evaluate the safety and efficiency of large volume wearable injectors for insulin and non-insulin drugs; majority are these studies are conducted in the US.

10. Considering the enormous opportunities associated with large volume wearable injectors, investors have actively extended funds, amounting to USD 1.4 billion, in the last few years.

11. In order to deal with the complexities associated with manufacturing and assembly of large volume wearable injectors, device developers are known to frequently engage the services of contract service providers.

12. Owing to the advantages offered by large volume wearable injectors for the delivery of insulin and non-insulin drugs, the market is anticipated to witness a steady growth in the foreseen future.

13. Driven by the growing demand for large volume wearable injectors for the delivery of non-insulin drugs, the overall market is anticipated to grow at an annualized rate of over 10% in the coming decade.

14. Growth in the large volume wearable injectors market for non-insulin drugs is anticipated to be primarily driven by the rising demand across various regions; North America is expected to capture the highest share by 2035.

15. The opportunity within the large volume wearable injectors market for insulin drugs is likely to be well-distributed across different type of device, usability and geographies.

WEARABLE INJECTORS MARKET FOR NON-INSULIN DRUGS: KEY SEGMENTS

Currently, Patch Pumps / Injectors Occupies the Largest Share of the Large Volume Wearable Injectors Market for Non-Insulin Drugs

Based on the type of device, the global large volume wearable injectors market for non-insulin drugs is segmented into patch pump / on body injectors and wearable infusion pump. It is worth highlighting that the market for infusion pumps / injectors for non-insulin drugs is likely to grow at a relatively higher CAGR, during the forecast period.

Reusable Devices Segment is the Fastest Growing Segment of the Large Volume Wearable Injectors Market for Non-Insulin Drugs

Based on the usability, the global large volume wearable injectors market for non-insulin drugs is segmented into disposable devices and reusable devices. It is worth highlighting that the market for reusable devices for non-insulin drugs is likely to grow at a relatively higher CAGR, during the forecast period.

At Present, Oncological Disorders Occupies the Largest Share of the Large Volume Wearable Injectors Market for Non-Insulin Drugs

Based on the therapeutic area, the market is segmented into autoimmune disorders, cardiovascular disorders, metabolic disorders, neurological disorders, oncological disorders and other disorders. While oncological disorders account for a relatively higher market share, it is worth highlighting that the autoimmune disorders segment is expected to witness substantial market growth in the coming years.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia, Middle East and North Africa, and Latin America. It is worth highlighting that, over the years, the market in Middle East and North Africa is expected to grow at a higher CAGR.

WEARABLE INJECTORS MARKET FOR INSULIN DRUGS: KEY SEGMENTS

Patch Pumps / Injectors Segment is the Fastest Growing Segment of the Large Volume Wearable Injectors Market for Insulin Drugs

Based on type of device, the global large volume wearable injectors market for insulin drugs is segmented into patch pump / on body injectors and wearable infusion pump. It is worth highlighting that the market for patch pumps / injectors for insulin drugs is likely to grow at a relatively higher CAGR, during the forecast period.

Currently, Reusable Devices Segment Occupies the Largest Share of the Large Volume Wearable Injectors Market for Insulin Drugs

Based on usability, the global large volume wearable injectors market for insulin drugs is segmented into disposable devices and reusable devices. It is worth highlighting that the market for reusable autoinjectors for insulin drugs is likely to dominate the market in the forthcoming years.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia, Middle East and North Africa, and Latin America. It is worth highlighting that, over the years, the market in Asia is expected to grow at a higher CAGR.

Example Players in the Wearable Injectors Market

• CCBio
• CeQur
• Debiotech
• E3D Elcam Drug Delivery Devices
• Eli Lilly
• Enable Injections
• Gerresheimer
• Insulet
• Medtronic
• Medtrum Technologies
• Pharmasense
• Roche
• Sonceboz
• Weibel CDS
• West Pharmaceuticals
• SOOIL Development

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

• Chief Executive Officer, Qlibrium
• Chief Executive Officer, Enable Injections
• Chief Executive Officer, Subcuject
• Former President and Chief Executive Officer, scPharmaceuticals
• Vice President and Chief Scientist, Elcam Medical
• Former Vice President and General Manager (Biologics), West Pharmaceutical Services
• Engineering Project Manager / Senior System Engineer, Debiotech
• Vice President, Marketing and Alliance Management, Eitan Medical

WEARABLE INJECTORS MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the wearable injectors market, focusing on key market segments, including [A] type of device, [B] usability, [C] therapeutic area and [D] key geographical regions.
• Market Impact Analysis: The report analyzes various factors such as drivers, restraints, opportunities, and challenges affecting market growth.
• Market Landscape of Wearable Injectors for the Delivery of Non-Insulin Drugs: A comprehensive evaluation of wearable injectors for the delivery of non-insulin drugs, considering various parameters, such as [A] status of development, [B] type of device, [C] usability, [D] type of dose, [E] type of drug container, [F] mode of drug filling, [G] container volume (mL), [H] route of administration, [I] mode of injection, [J] mechanism of action, [K] type of technology, [L] availability of connectivity feature, [M] type of compatible drug, [N] compatibility with high viscosity drugs and [O] therapeutic areas. In addition, the chapter presents the market landscape of companies manufacturing large volume wearable injectors for non-insulin drug delivery, including information on their [P] year of establishment, [Q] company size (in terms of number of employees), and [R] location of headquarters.
• Market Landscape of Wearable Injection Device and Drug Combinations for the Delivery of Non-Insulin Drugs: A comprehensive evaluation of wearable injection device and drug combinations for the delivery of non-insulin drugs, considering various parameters, such as [A] status of development, [B] type of device, [C] type of drug container, [D] container volume (mL), [E] route of administration, [F] mode of injection, [G] type of compatible drug, [H] mechanism of action / driving force, [I] type of technology and [J] therapeutic area. In addition, the chapter presents the market landscape of companies manufacturing drug-device combinations for non-insulin drug delivery, including information on their [A] year of establishment, [B] company size (in terms of number of employees), and [C] location of headquarters.
• Market Landscape of Wearable Injectors for the Delivery of Insulin Drugs: A comprehensive evaluation of wearable injectors for the delivery of insulin drugs, considering various parameters, such as [A] status of development, [B] type of device, [C] usability, [D] type of dose, [E] container volume (mL), [F] type of diabetes, [G] type of combination insulin, [H] period of use (days), [I] type of device control feature, [J] availability of interoperable devices, [K] availability of continuous glucose monitoring (CGM) / blood glucose meters (BGM) system, [L] availability of automatic insulin delivery (AID) / artificial pancreas, [M] type of automated insulin delivery feature (AID), [N] availability of connectivity feature and [O] waterproof capabilities. In addition, the chapter presents the market landscape of companies manufacturing large volume wearable injectors for insulin delivery, including information on their [P] year of establishment, [Q] company size (in terms of number of employees), and [R] location of headquarters.
• Product Competitiveness Analysis: A comprehensive competitive analysis of various wearable injectors, examining factors such as [A] company strength, [B] product competitiveness and [C] company size.
• Company Profiles: In-depth profiles of key industry players developing wearable injectors, focusing on [A] company overviews, [B] financial information (if available), [C] product portfolio, [D] an insightful recent development and [E] an informed future outlook.
• Product Profiles: A list of tabulated profiles of wearable drug device combination products featuring [A] drug specifications, [B] mechanism of action, [C] current status of development, [D] dosage frequency and [E] information on sales (if available).
• Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2015, based on several relevant parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] type of device, [E] most active players (in terms of number of partnerships), [F] and [G] geography.
• Key Acquisition Targets: A detailed analysis of the key acquisition targets, taking into consideration the historical trend of the acquisition activity of the players that have acquired other firms, since 2000. It offers a means for other industry stakeholders to identify potential acquisition targets.
• Patent Analysis: Detailed analysis of various patents filed / granted related to wearable injectors based on [A] type of patent, [B] patent publication year, [C] jurisdiction, [D] CPC symbol, [E] type of organization, [F] emerging focus area and [G] most active players (based on the number of patents). Additionally, the chapter includes patent benchmarking analysis and insightful patent valuation analysis, highlighting the leading patents (in terms of number of citations).
• Likely Drug Candidates: A list of marketed drugs and therapies, as well as pipeline candidates, that are expected to be developed in conjunction with wearable injectors in the near future. This list is based on a thorough analysis of potential candidates (both marketed and clinical-stage drugs) based on several relevant parameters, such as [A] type of drug molecule, [B] phase of development, [C] indication, [D] dosing frequency, [E] type of therapy, [F] method of administration and [G] route of administration.
• Clinical Trial Analysis: Examination of completed, ongoing, and planned clinical studies of various wearable injectors based on parameters like [A] trial recruitment status, [B] trial registration year, [C] trial phase, [D] study design, [E] type of sponsor / collaborator, [F] leading players (based on the number of registered trials), [G] key focus area, [H] therapeutic area and [I] geography.
• Funding and Investment Analysis: A detailed evaluation of the investments made in the this domain, encompassing seed financing, venture capital, capital raised from IPOs, secondary offerings, grants / awards, other equity and debt financing based on several parameters, such as [A] year of funding, [B] amount invested by year, [C] type of funding, [D] type of device, [E] target disease indication, [F] most active players (in terms of number of funding instances and amount invested), [G] leading investors (in terms of number of funding instances) and [H] geography.
• Case Study: A case study examining the role of contract manufacturing organizations in the overall manufacturing process and supply chain of wearable injectors. This study includes details on the services provided by contract service providers for the production of various device components, such as primary containers, infusion sets, adhesives, closures and injection moldings.
• Regulatory Landscape: A discussion on general regulatory guidelines for medical device approvals across North America, Europe, Asia-Pacific and rest of the world. It also includes an insightful multi-dimensional heat map analysis, featuring a comparison of the contemporary regulatory and reimbursement scenarios in key geographies across the globe.
• SWOT Analysis: A SWOT analysis, focusing on key drivers and challenges that are likely to impact the industry’s evolution.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What kind of partnership models are commonly adopted by industry stakeholders?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older